Erlotinib plus bevacizumab as an effective treatment for leptomeningeal metastases from EGFR mutation-positive non-small cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

Erlotinib plus bevacizumab as an effective treatment for leptomeningeal metastases from EGFR mutation-positive non-small cell lung cancer

18

Citations

8

References

2016

Year

Yoshihiko Sakata, Kodai Kawamura, Naoki Shingu, Kazuya Ichikado

Leptomeningeal MetastasesMedicinePathologyEffective TreatmentBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1